

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * polyketide metabolic process (GO:0030638) | 9.92963378 |
| 2 | * doxorubicin metabolic process (GO:0044598) | 9.92963378 |
| 3 | * daunorubicin metabolic process (GO:0044597) | 9.92963378 |
| 4 | * aminoglycoside antibiotic metabolic process (GO:0030647) | 8.68270463 |
| 5 | cellular glucuronidation (GO:0052695) | 6.56027957 |
| 6 | glucuronate metabolic process (GO:0019585) | 6.36969373 |
| 7 | uronic acid metabolic process (GO:0006063) | 6.36969373 |
| 8 | ethanol oxidation (GO:0006069) | 5.69155414 |
| 9 | * primary alcohol catabolic process (GO:0034310) | 5.45516493 |
| 10 | * glycoside metabolic process (GO:0016137) | 5.30182466 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.29614721 |
| 12 | intestinal absorption (GO:0050892) | 5.04068583 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.94426094 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.94426094 |
| 15 | ethanol metabolic process (GO:0006067) | 4.88385828 |
| 16 | flavonoid metabolic process (GO:0009812) | 4.88175551 |
| 17 | urea metabolic process (GO:0019627) | 4.85139781 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 4.77920293 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.73955087 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62928446 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 4.62928446 |
| 22 | urea cycle (GO:0000050) | 4.56479827 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.55411697 |
| 24 | regulation of complement activation (GO:0030449) | 4.52069779 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.50645513 |
| 26 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.46283974 |
| 27 | complement activation, alternative pathway (GO:0006957) | 4.43182909 |
| 28 | bile acid metabolic process (GO:0008206) | 4.40443986 |
| 29 | bile acid and bile salt transport (GO:0015721) | 4.39492000 |
| 30 | drug catabolic process (GO:0042737) | 4.35170453 |
| 31 | drug metabolic process (GO:0017144) | 4.32247185 |
| 32 | exogenous drug catabolic process (GO:0042738) | 4.25518312 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.24016646 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.23637145 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.22564880 |
| 36 | * quinone metabolic process (GO:1901661) | 3.93499289 |
| 37 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91160714 |
| 38 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91160714 |
| 39 | * progesterone metabolic process (GO:0042448) | 3.90700996 |
| 40 | NADH metabolic process (GO:0006734) | 3.82891915 |
| 41 | angiotensin maturation (GO:0002003) | 3.79918790 |
| 42 | protein carboxylation (GO:0018214) | 3.79217690 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79217690 |
| 44 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76814085 |
| 45 | drug transmembrane transport (GO:0006855) | 3.75569354 |
| 46 | * primary alcohol metabolic process (GO:0034308) | 3.75515515 |
| 47 | phenylpropanoid metabolic process (GO:0009698) | 3.74520522 |
| 48 | hormone catabolic process (GO:0042447) | 3.72474583 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.69142298 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 3.62284994 |
| 51 | macromolecular complex remodeling (GO:0034367) | 3.62284994 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.62284994 |
| 53 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.60372092 |
| 54 | fibrinolysis (GO:0042730) | 3.60107177 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 3.58946060 |
| 56 | glyoxylate metabolic process (GO:0046487) | 3.52429697 |
| 57 | phospholipid efflux (GO:0033700) | 3.48630351 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44949690 |
| 59 | acute-phase response (GO:0006953) | 3.40017402 |
| 60 | negative regulation of hemostasis (GO:1900047) | 3.37388078 |
| 61 | negative regulation of blood coagulation (GO:0030195) | 3.37388078 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.32248239 |
| 63 | protein-lipid complex assembly (GO:0065005) | 3.29680975 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.29654010 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.29654010 |
| 66 | L-ascorbic acid metabolic process (GO:0019852) | 3.29326342 |
| 67 | * cellular aldehyde metabolic process (GO:0006081) | 3.28769121 |
| 68 | negative regulation of coagulation (GO:0050819) | 3.28578596 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.26984556 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.25802490 |
| 71 | diacylglycerol metabolic process (GO:0046339) | 3.25403207 |
| 72 | omega-hydroxylase P450 pathway (GO:0097267) | 3.23390766 |
| 73 | alpha-linolenic acid metabolic process (GO:0036109) | 3.23285324 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.23001440 |
| 75 | cholesterol efflux (GO:0033344) | 3.22539708 |
| 76 | drug transport (GO:0015893) | 3.22279200 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.19160654 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.19160654 |
| 79 | regulation of plasminogen activation (GO:0010755) | 3.18916072 |
| 80 | digestion (GO:0007586) | 3.16551964 |
| 81 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.16457691 |
| 82 | positive regulation of lipid catabolic process (GO:0050996) | 3.15774334 |
| 83 | cholesterol homeostasis (GO:0042632) | 3.15747809 |
| 84 | bile acid biosynthetic process (GO:0006699) | 3.14264288 |
| 85 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.14053596 |
| 86 | negative regulation of protein activation cascade (GO:2000258) | 3.13201693 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.10357931 |
| 88 | sterol homeostasis (GO:0055092) | 3.10328407 |
| 89 | protein activation cascade (GO:0072376) | 3.10264726 |
| 90 | xenobiotic catabolic process (GO:0042178) | 3.07209503 |
| 91 | triglyceride catabolic process (GO:0019433) | 3.06778191 |
| 92 | plasma lipoprotein particle organization (GO:0071827) | 3.06323121 |
| 93 | negative regulation of wound healing (GO:0061045) | 3.05418957 |
| 94 | xenobiotic metabolic process (GO:0006805) | 3.04886561 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.04175392 |
| 96 | arginine metabolic process (GO:0006525) | 3.03790934 |
| 97 | lipoprotein metabolic process (GO:0042157) | 3.02182135 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.00643721 |
| 99 | lipoprotein transport (GO:0042953) | 3.00305103 |
| 100 | acylglycerol catabolic process (GO:0046464) | 2.99554867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.39103322 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.84514691 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.75876910 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.16021719 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.00596192 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82420502 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.30897344 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.10819515 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.95739247 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.76281810 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69438526 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.66359901 |
| 13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.65251516 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58000848 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.36148076 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34944163 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.26067075 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23856798 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19255112 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.17841266 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.17242660 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.14120465 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07852632 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06613731 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05424925 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04130455 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92983915 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.92688333 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85928818 |
| 30 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.82567789 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78828239 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76589608 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75900858 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75391558 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.73509520 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61712804 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52083011 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46689672 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40461302 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.40419974 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39883270 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37069108 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35669511 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31814738 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30746726 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29839878 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29415840 |
| 48 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24966241 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14583500 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14464997 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14464997 |
| 52 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10798922 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10585253 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09688342 |
| 55 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09211416 |
| 56 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07681489 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05602648 |
| 58 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02851434 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02448312 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01830553 |
| 61 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99656702 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97883987 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96126338 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94829550 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92420098 |
| 66 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91240742 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90525926 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89929553 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89589758 |
| 70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88897311 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88096662 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87463898 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87461453 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86237693 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84619571 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84531002 |
| 77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84045710 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82930223 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82403232 |
| 80 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80988722 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79774227 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79538581 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78581472 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78148432 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76919891 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76919891 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.76032619 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74887549 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73974125 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72660086 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72047065 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71791041 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71551664 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71143858 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70504501 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70089184 |
| 97 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.70037325 |
| 98 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69938837 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69765248 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69056053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.03742318 |
| 2 | MP0005360_urolithiasis | 6.13955833 |
| 3 | MP0005365_abnormal_bile_salt | 5.11416649 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.83428768 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.03082936 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.80000507 |
| 7 | MP0003868_abnormal_feces_composition | 3.20519864 |
| 8 | MP0003252_abnormal_bile_duct | 2.99896307 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.77973240 |
| 10 | MP0009840_abnormal_foam_cell | 2.70736627 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.67895917 |
| 12 | MP0005670_abnormal_white_adipose | 2.59464973 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.54829784 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.29805428 |
| 15 | MP0003195_calcinosis | 2.16873548 |
| 16 | MP0005332_abnormal_amino_acid | 2.15498316 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.01952375 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.96787328 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.76413669 |
| 20 | MP0000609_abnormal_liver_physiology | 1.66871546 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.60116544 |
| 22 | MP0001764_abnormal_homeostasis | 1.53644651 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.46435812 |
| 24 | MP0002971_abnormal_brown_adipose | 1.39733511 |
| 25 | MP0003186_abnormal_redox_activity | 1.36892810 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.35228905 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.31099653 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.29788353 |
| 29 | MP0009697_abnormal_copulation | 1.22416776 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20307225 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.18544633 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.10037773 |
| 33 | MP0002132_abnormal_respiratory_system | 1.09698821 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.08475845 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.04929092 |
| 36 | MP0004147_increased_porphyrin_level | 1.02777938 |
| 37 | MP0005451_abnormal_body_composition | 1.01481241 |
| 38 | MP0005165_increased_susceptibility_to | 0.98266943 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 0.96196094 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 0.95436139 |
| 41 | MP0001661_extended_life_span | 0.93482567 |
| 42 | MP0005464_abnormal_platelet_physiology | 0.92396808 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 0.91787983 |
| 44 | MP0000598_abnormal_liver_morphology | 0.91559798 |
| 45 | MP0005164_abnormal_response_to | 0.90942902 |
| 46 | MP0001664_abnormal_digestion | 0.90799956 |
| 47 | MP0005023_abnormal_wound_healing | 0.89938475 |
| 48 | MP0008469_abnormal_protein_level | 0.88807286 |
| 49 | MP0004272_abnormal_basement_membrane | 0.86092194 |
| 50 | MP0000013_abnormal_adipose_tissue | 0.85406979 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 0.85366847 |
| 52 | MP0003300_gastrointestinal_ulcer | 0.84448765 |
| 53 | MP0005408_hypopigmentation | 0.84371701 |
| 54 | MP0004264_abnormal_extraembryonic_tissu | 0.84242917 |
| 55 | MP0005334_abnormal_fat_pad | 0.83923940 |
| 56 | MP0009642_abnormal_blood_homeostasis | 0.82789081 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 0.82681146 |
| 58 | MP0002136_abnormal_kidney_physiology | 0.82467699 |
| 59 | MP0003950_abnormal_plasma_membrane | 0.81804562 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.80889020 |
| 61 | MP0001881_abnormal_mammary_gland | 0.80341795 |
| 62 | MP0009115_abnormal_fat_cell | 0.80057981 |
| 63 | MP0005166_decreased_susceptibility_to | 0.79577377 |
| 64 | MP0009379_abnormal_foot_pigmentation | 0.79384317 |
| 65 | MP0003959_abnormal_lean_body | 0.78639441 |
| 66 | MP0005376_homeostasis/metabolism_phenot | 0.78405563 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.78262515 |
| 68 | MP0000604_amyloidosis | 0.77987513 |
| 69 | MP0001756_abnormal_urination | 0.77193823 |
| 70 | MP0003075_altered_response_to | 0.76395874 |
| 71 | MP0005535_abnormal_body_temperature | 0.75912393 |
| 72 | MP0002970_abnormal_white_adipose | 0.75751072 |
| 73 | MP0005409_darkened_coat_color | 0.75167200 |
| 74 | MP0005448_abnormal_energy_balance | 0.71088531 |
| 75 | MP0000858_altered_metastatic_potential | 0.70784028 |
| 76 | MP0003718_maternal_effect | 0.69556033 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.67718746 |
| 78 | MP0009763_increased_sensitivity_to | 0.66611405 |
| 79 | MP0003866_abnormal_defecation | 0.65883529 |
| 80 | MP0000249_abnormal_blood_vessel | 0.65665067 |
| 81 | MP0000477_abnormal_intestine_morphology | 0.62805741 |
| 82 | MP0006138_congestive_heart_failure | 0.61777370 |
| 83 | MP0008260_abnormal_autophagy | 0.60662512 |
| 84 | MP0001873_stomach_inflammation | 0.59651339 |
| 85 | MP0005395_other_phenotype | 0.58697969 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.58680363 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.57689869 |
| 88 | MP0002796_impaired_skin_barrier | 0.56638247 |
| 89 | MP0004043_abnormal_pH_regulation | 0.56255961 |
| 90 | MP0005083_abnormal_biliary_tract | 0.54739188 |
| 91 | MP0000467_abnormal_esophagus_morphology | 0.54647198 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.54575971 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.52973991 |
| 94 | MP0001663_abnormal_digestive_system | 0.52743419 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.52650087 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.52400206 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.51500332 |
| 98 | MP0003879_abnormal_hair_cell | 0.50259122 |
| 99 | MP0000490_abnormal_crypts_of | 0.49456686 |
| 100 | MP0005501_abnormal_skin_physiology | 0.49186034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64897830 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.05980998 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.74147214 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.69085399 |
| 5 | Complement deficiency (HP:0004431) | 5.56893158 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 5.02887694 |
| 7 | Fat malabsorption (HP:0002630) | 4.94840521 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.92461747 |
| 9 | Abnormality of complement system (HP:0005339) | 4.84198231 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.64473345 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 4.45985901 |
| 12 | Hydroxyprolinuria (HP:0003080) | 4.45985901 |
| 13 | Steatorrhea (HP:0002570) | 4.38006792 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.24543738 |
| 15 | Xanthomatosis (HP:0000991) | 3.90589570 |
| 16 | Glomerulonephritis (HP:0000099) | 3.80163154 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.52283556 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.47226643 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.43355215 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.42952366 |
| 21 | Hyperammonemia (HP:0001987) | 3.38083921 |
| 22 | Vascular calcification (HP:0004934) | 3.36941738 |
| 23 | Joint hemorrhage (HP:0005261) | 3.20871386 |
| 24 | Cardiovascular calcification (HP:0011915) | 3.09712217 |
| 25 | Nephritis (HP:0000123) | 3.03782748 |
| 26 | Malnutrition (HP:0004395) | 2.99833364 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93998882 |
| 28 | Vertebral compression fractures (HP:0002953) | 2.85424384 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.80963421 |
| 30 | Ileus (HP:0002595) | 2.71664689 |
| 31 | Hypercholesterolemia (HP:0003124) | 2.71180656 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.69775254 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.67369742 |
| 34 | Nausea (HP:0002018) | 2.65337946 |
| 35 | Spontaneous abortion (HP:0005268) | 2.62949617 |
| 36 | Acanthocytosis (HP:0001927) | 2.60713157 |
| 37 | Rickets (HP:0002748) | 2.57631342 |
| 38 | Cerebral palsy (HP:0100021) | 2.51459975 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 2.45267630 |
| 40 | Abnormal sex determination (HP:0012244) | 2.45045507 |
| 41 | Sex reversal (HP:0012245) | 2.45045507 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.43911172 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.43185050 |
| 44 | Glycosuria (HP:0003076) | 2.43185050 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33133561 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32344428 |
| 47 | Proximal tubulopathy (HP:0000114) | 2.31711981 |
| 48 | Epidermoid cyst (HP:0200040) | 2.29563538 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.29159065 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.28155772 |
| 51 | Tetraparesis (HP:0002273) | 2.26584134 |
| 52 | Hypertriglyceridemia (HP:0002155) | 2.25621569 |
| 53 | Amyloidosis (HP:0011034) | 2.25582096 |
| 54 | Mitral stenosis (HP:0001718) | 2.24473761 |
| 55 | Potter facies (HP:0002009) | 2.23934218 |
| 56 | Facial shape deformation (HP:0011334) | 2.23934218 |
| 57 | Focal segmental glomerulosclerosis (HP:0000097) | 2.21350758 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.20697219 |
| 59 | Glomerulosclerosis (HP:0000096) | 2.20638523 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.19295267 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19295267 |
| 62 | Back pain (HP:0003418) | 2.17568777 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 2.17283746 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.16339451 |
| 65 | Rhabdomyolysis (HP:0003201) | 2.13630432 |
| 66 | Protrusio acetabuli (HP:0003179) | 2.08178801 |
| 67 | Abnormality of carpal bone ossification (HP:0006257) | 2.07737875 |
| 68 | Increased serum ferritin (HP:0003281) | 2.07303723 |
| 69 | Pancreatitis (HP:0001733) | 2.06527025 |
| 70 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06298210 |
| 71 | Widely patent fontanelles and sutures (HP:0004492) | 2.06056682 |
| 72 | Gingival bleeding (HP:0000225) | 2.04786100 |
| 73 | Hyperglycinuria (HP:0003108) | 2.04319344 |
| 74 | Myocardial infarction (HP:0001658) | 2.03694933 |
| 75 | Pigmentary retinal degeneration (HP:0001146) | 2.02696393 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 2.00666997 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00666997 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00463563 |
| 79 | Abnormality of glycine metabolism (HP:0010895) | 2.00463563 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 2.00424694 |
| 81 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98652802 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98502425 |
| 83 | Hypoglycemic coma (HP:0001325) | 1.97769001 |
| 84 | Flat acetabular roof (HP:0003180) | 1.97679424 |
| 85 | Metabolic acidosis (HP:0001942) | 1.97481673 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96531231 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96531231 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96531231 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 1.95905165 |
| 90 | Skin nodule (HP:0200036) | 1.95074175 |
| 91 | Purpura (HP:0000979) | 1.93508751 |
| 92 | Gout (HP:0001997) | 1.92406506 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 1.92167159 |
| 94 | Increased purine levels (HP:0004368) | 1.91238887 |
| 95 | Hyperuricemia (HP:0002149) | 1.91238887 |
| 96 | Alkalosis (HP:0001948) | 1.90709499 |
| 97 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90374251 |
| 98 | Exocrine pancreatic insufficiency (HP:0001738) | 1.85812584 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 1.84261446 |
| 100 | Acanthosis nigricans (HP:0000956) | 1.84084231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.87477827 |
| 2 | MST1R | 5.12715688 |
| 3 | EPHA2 | 3.39453409 |
| 4 | LMTK2 | 3.14988215 |
| 5 | TESK1 | 2.66244724 |
| 6 | RIPK1 | 2.41290497 |
| 7 | MET | 2.30156886 |
| 8 | ACVR1B | 2.28567879 |
| 9 | SCYL2 | 2.28031432 |
| 10 | IRAK3 | 2.27926578 |
| 11 | FGFR4 | 2.25587129 |
| 12 | PBK | 1.95912615 |
| 13 | PRKG2 | 1.85805579 |
| 14 | DDR2 | 1.81922189 |
| 15 | NME2 | 1.81103718 |
| 16 | MAP3K12 | 1.80047186 |
| 17 | TBK1 | 1.72298796 |
| 18 | PDK2 | 1.67266986 |
| 19 | MAPKAPK3 | 1.64046957 |
| 20 | ERBB4 | 1.61257313 |
| 21 | NEK1 | 1.38002577 |
| 22 | ABL2 | 1.37237124 |
| 23 | TRIB3 | 1.29069557 |
| 24 | ARAF | 1.28909278 |
| 25 | PDGFRA | 1.27241282 |
| 26 | EIF2AK1 | 1.26602518 |
| 27 | MAPK11 | 1.23961549 |
| 28 | BCKDK | 1.22864735 |
| 29 | MAP3K2 | 1.19886180 |
| 30 | MYLK | 1.18164503 |
| 31 | MAP3K3 | 1.17317270 |
| 32 | TGFBR2 | 1.16093437 |
| 33 | PRKAA2 | 1.10545327 |
| 34 | PIM2 | 1.07193792 |
| 35 | TYK2 | 1.04935033 |
| 36 | TESK2 | 1.02729600 |
| 37 | PIK3CA | 1.00619538 |
| 38 | FLT3 | 0.99550334 |
| 39 | FGFR3 | 0.98419182 |
| 40 | CDK8 | 0.96164315 |
| 41 | LIMK1 | 0.95334455 |
| 42 | SIK1 | 0.93141186 |
| 43 | MST4 | 0.91051417 |
| 44 | PRPF4B | 0.90595697 |
| 45 | EPHB2 | 0.90211007 |
| 46 | TAOK3 | 0.88845639 |
| 47 | PAK4 | 0.84968311 |
| 48 | MAP3K13 | 0.84438909 |
| 49 | EPHA3 | 0.83903111 |
| 50 | MATK | 0.81280538 |
| 51 | DAPK1 | 0.80749011 |
| 52 | PDPK1 | 0.80691593 |
| 53 | MAP3K1 | 0.80588268 |
| 54 | RPS6KB2 | 0.77777451 |
| 55 | CDK9 | 0.76978069 |
| 56 | EIF2AK3 | 0.76174863 |
| 57 | LATS1 | 0.74234872 |
| 58 | STK39 | 0.74170052 |
| 59 | NEK9 | 0.71215771 |
| 60 | PTK2 | 0.68923710 |
| 61 | FER | 0.67061440 |
| 62 | CDC42BPA | 0.63625928 |
| 63 | PRKACG | 0.62303210 |
| 64 | MAP2K2 | 0.62155997 |
| 65 | PTK6 | 0.58150537 |
| 66 | ZAP70 | 0.56959145 |
| 67 | EPHB1 | 0.55625293 |
| 68 | TRPM7 | 0.53204856 |
| 69 | IGF1R | 0.52524711 |
| 70 | MELK | 0.51671805 |
| 71 | LATS2 | 0.51544583 |
| 72 | JAK3 | 0.50905668 |
| 73 | MAP3K11 | 0.49638235 |
| 74 | KIT | 0.47279069 |
| 75 | ICK | 0.46606321 |
| 76 | MAPKAPK5 | 0.46201899 |
| 77 | CAMK2G | 0.45577006 |
| 78 | PIK3CG | 0.45494477 |
| 79 | KDR | 0.43910405 |
| 80 | CSF1R | 0.43010622 |
| 81 | BMPR2 | 0.43000550 |
| 82 | BMX | 0.41923210 |
| 83 | SRC | 0.41378772 |
| 84 | STK16 | 0.40470998 |
| 85 | MAP2K1 | 0.39496031 |
| 86 | MAP3K6 | 0.38565571 |
| 87 | GRK6 | 0.38240648 |
| 88 | CDK6 | 0.38001557 |
| 89 | GSK3A | 0.34548014 |
| 90 | PDK1 | 0.33966964 |
| 91 | SMG1 | 0.33566324 |
| 92 | PRKCD | 0.33455373 |
| 93 | LRRK2 | 0.30616641 |
| 94 | MAP3K7 | 0.30085477 |
| 95 | PRKCA | 0.29395733 |
| 96 | STK38 | 0.27725913 |
| 97 | ILK | 0.26656738 |
| 98 | DAPK3 | 0.26176834 |
| 99 | CAMK2D | 0.26103305 |
| 100 | GRK5 | 0.25544237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.89671236 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.68088695 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.01690927 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.99161656 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.94331370 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.83855241 |
| 7 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.67816263 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.57438549 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.55671877 |
| 10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.55169191 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44467719 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.43412005 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.31245956 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30453347 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.28168869 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26980142 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.17916371 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17626743 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.17209833 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89911248 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.84681637 |
| 22 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.81583971 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73073275 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.65243443 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.64047199 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.63154417 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60826006 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.54433379 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49431626 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.48976637 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47412107 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43965837 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.42131179 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37729418 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36894931 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36152236 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32200532 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31485783 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29995953 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25487549 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.22671974 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17222078 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15635759 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14904537 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13118589 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12418999 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09024597 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05629731 |
| 49 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04761230 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03804139 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03674169 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00159728 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99308424 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98401589 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94683927 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94258914 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89051069 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86760733 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76546153 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76417110 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.75848700 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.75655768 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69079510 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66781798 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66183781 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64367649 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61883134 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55848030 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53481579 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48947235 |
| 71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48562578 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44224166 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38933172 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31852740 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31152335 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30036825 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29369767 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27858876 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27635781 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.27297640 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26546858 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.23849647 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.21302544 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20774550 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.15102742 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.14371271 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.10494456 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10036153 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09810164 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09706689 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.09629291 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.08440118 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.00254322 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | -0.0781419 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0683911 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.0626494 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0567984 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0551242 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.0502907 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0065613 |

